Integrating Enzyme‐DNA Complex and CRISPR/Cas12a for Robust Norovirus Detection

ABSTRACT Human norovirus (NoV) is a primary cause of acute gastroenteritis in children, making accurate and rapid detection essential for effective disease prevention and control. In this study, we developed a sensitive and efficient platform for pathogen nucleic acid detection by integrating asymmetric nucleic acid sequence‐based amplification (asymmetric NASBA), enzyme‐DNA molecular complex, and the clustered regularly interspaced short palindromic repeats (CRISPR) system, namely an A‐enDMC platform. The target recognition capability of the enzyme‐DNA complex operates independently from the signal amplification function of the CRISPR system. By decoupling the CRISPR reaction from the dependence on specific target sequences, the platform's universality and modularity are enhanced. The assay is fast (< 1.5 h), highly sensitive (< 5 copies/µL), and demonstrates no cross‐reactivity with other common viruses. Compared to the widely used RT‐qPCR method, the platform demonstrates high consistency in detection results, with the detection coincidence rate of 96.77% and a kappa value of 0.87. This platform provides a versatile technological tool for highly sensitive and specific RNA detection, demonstrating its extensive potential in real sample analysis.